Kratom vs. CBD: A Botanical and Chemical Comparison
Kratom and CBD are increasingly appearing together in discussions about plant-based alternatives. Both are botanical in origin, both operate in legal grey areas, and both have attracted considerable attention in recent years.
But the similarities end there. Chemically, botanically and legally, kratom and CBD are fundamentally different. This article explains the differences – without claims about effects, based solely on plant science and chemistry.
The Plants: Where Do They Come From?
Kratom comes from Mitragyna speciosa, a tree from the Rubiaceae family (madder family) – the same family as coffee. The plant grows natively in the tropical rainforests of Southeast Asia. The leaves are harvested, then dried, powdered or extracted.
CBD (cannabidiol) comes from Cannabis sativa – hemp. This plant belongs to the Cannabaceae family and is distributed worldwide in temperate to tropical climate zones. CBD is mainly obtained from industrial hemp, primarily from the flowers and leaves of the plant.
These two plants have nothing to do with each other. They originate from different continents, different plant families and have completely different botanical properties.
The Active Compounds: Alkaloids vs. Cannabinoids
| Property | Kratom (Mitragynine) | CBD (Cannabidiol) |
|---|---|---|
| Compound class | Indole alkaloid | Cannabinoid |
| Source plant | Mitragyna speciosa | Cannabis sativa |
| Plant family | Rubiaceae | Cannabaceae |
| Solubility | Lipophilic (fat-soluble) | Lipophilic (fat-soluble) |
| Nitrogen in molecule | Yes | No |
| Known receptor interaction | μ-opioid receptor (partial) | CB1/CB2 receptors, others |
Alkaloids are nitrogen-containing organic compounds. Cannabinoids are terpenophenoloid compounds that contain no nitrogen atom and are structurally completely different. The chemical similarity between mitragynine and CBD is virtually non-existent.
Legal Status in Germany and the EU
CBD: Regulated as a food ingredient under Novel Food (actively enforced since 2019). Not listed under the BtMG. Products exist in a legal grey area – large market, inconsistent regulation.
Kratom: Also not listed under the BtMG – possession and sale in Germany are legal. Also subject to the Novel Food Regulation: sale as food is not permitted without authorisation. Products are sold with the notice "not intended for human consumption".
Ironically, CBD and kratom find themselves in a very similar legal framework – both grappling with the Novel Food Regulation, both lacking a clear status as food supplements.
Market Development: Two Different Trajectories
CBD has experienced significant market expansion. In Europe alone, the CBD market is estimated at several billion euros. Large corporations are investing, supermarkets are listing CBD products – social acceptance is high.
Kratom has a considerably smaller but loyal market. The community is active, knowledge is growing – but social awareness in Europe is still limited. Those who offer high-quality, transparent products now can establish themselves as a reliable brand in a market that is not yet saturated.
Conclusion
Kratom and CBD are two different plants with two chemically fundamentally different compound classes. What connects them: both are botanically extracted, both operate in the same regulatory grey area of the Novel Food Regulation. What separates them: everything else – botany, chemistry, origin, receptor profile and market development.
Legal Notice: This article is for informational purposes only and does not constitute legal advice. The content is not intended to encourage consumption. Laws may change; the applicable regulations and information from official authorities shall prevail. Image source: https://www.kratoein.com/